Search results
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 4 days agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with psoriasis will develop ...
Which Vitamins Are Good For Arthritis?
Shape via Yahoo News· 5 days agoGeorgiy Brusovanik, MD, an orthopedist and minimally invasive spine surgeon, says there are two main types of arthritis: inflammatory and...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 2 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
Amgen (NASDAQ:AMGN) Rating Increased to Outperform at William Blair
ETF DAILY NEWS· 5 hours agoAmgen (NASDAQ:AMGN – Get Free Report) was upgraded by William Blair from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Friday, MarketBeat ...
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 4 days agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 3 days agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
FDA OKs High-Concentration of Adalimumab Biosimilar Cyltezo
Medscape· 3 days agoUnlike the low-concentration formulation of adalimumab-adbm, launched July 1, 2023, this high-concentration version has not yet been granted an interchangeability designation.
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 2 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 2 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Ventyx...
Morningstar· 7 days agoPomerantz LLP announces that a class action lawsuit has been filed against Ventyx Biosciences, Inc. ("Ventyx" or the "Company") (NASDAQ: VTYX) and certain officers. The class action, filed in ...